Regentatlantic Capital LLC Bristol Myers Squibb CO Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Regentatlantic Capital LLC holds 107,166 shares of BMY stock, worth $6.17 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

107,166

Previous 104,074 2.97%

Holding current value

$6.17 Million

Previous $8.01 Million 4.94%

% of portfolio

0.23%

Previous 0.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $401 - $237,589	3,092 Added 2.97%	107,166 $7.62 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $213,430 - $235,061	2,939 Added 2.91%	104,074 $8.01 Million
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $1.13 Million - $1.36 Million	18,453 Added 22.32%	101,135 $7.39 Million
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $665,387 - $775,685	-12,407 Reduced 13.05%	82,682 $5.16 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $703,235 - $823,749	11,885 Added 14.28%	95,089 $5.63 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $302,677 - $329,616	4,889 Added 6.24%	83,204 $5.56 Million
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $387,964 - $436,346	6,538 Added 9.11%	78,315 $4.94 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $8,430 - $9,552	146 Added 0.2%	71,777 $4.45 Million
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $198,937 - $220,448	-3,464 Reduced 4.61%	71,631 $4.32 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $637,337 - $745,110	11,626 Added 18.32%	75,095 $4.42 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $686,024 - $996,952	14,785 Added 30.37%	63,469 $3.54 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $1.33 Million - $1.74 Million	27,047 Added 125.0%	48,684 $3.13 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $215,731 - $255,781	5,044 Added 30.4%	21,637 $1.1 Million
Q2 2019 Jul 23, 2019	SELL	$44.62 - $49.34 $67,911 - $75,095	-1,522 Reduced 8.4%	16,593 $752,000
Q1 2019 May 03, 2019	SELL	$45.12 - $53.8 $21,702 - $25,877	-481 Reduced 2.59%	18,115 $864,000
Q4 2018 Jan 30, 2019	SELL	$48.76 - $63.23 $31,206 - $40,467	-640 Reduced 3.33%	18,596 $967,000
Q3 2018 Oct 30, 2018	BUY	$55.19 - $62.25 $238,034 - $268,484	4,313 Added 28.9%	19,236 $1.19 Million
Q2 2018 Jul 31, 2018	SELL	$50.53 - $62.98 $17,685 - $22,043	-350 Reduced 2.29%	14,923 $826,000
Q1 2018 Apr 23, 2018	SELL	$59.92 - $68.98 $26,125 - $30,075	-436 Reduced 2.78%	15,273 $966,000
Q4 2017 Jan 23, 2018	BUY	$59.94 - $65.35 $37,342 - $40,713	623 Added 4.13%	15,709 $963,000
Q3 2017 Oct 25, 2017	BUY	$55.23 - $63.74 $833,199 - $961,581	15,086	15,086 $962,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Bristol Myers Squibb CO Transaction History